Find a Member

Full Investigator List

Finding the right member is just a click away.

Kenneth Perkins

Kenneth Perkins

Program: Biobehavioral Cancer Control

412-246-5397 WPIC
3811 O'Hara Street
Pittsburgh PA

Dr. Perkins is author or co-author of over 200 publications, primarily on behavioral aspects of nicotine or tobacco smoking. Among his ongoing projects, one focuses on nicotine's effects in enhancing reinforcement from various non-drug rewards that are independent of nicotine intake, which has been demonstrated by others in animal models, but only recently shown in humans by Dr. Perkins. This reinforcement enhancing effect is separate from nicotine's well-known primary and secondary reinforcing effects. In another recent project, an efficient procedure for screening novel medications to treat tobacco dependence was developed and validated (i.e., FDA early phase 2). This project continues, as the procedure is now being used for its ultimate purpose, to evaluate efficacy for cessation in new compounds, and it may be applicable to screening novel medications to treat other drug dependence problems. A third, newer project aims to determine the lowest dose of nicotine via cigarettes that can be discriminated (i.e., perceived) from placebo, which could help inform public policy on tobacco regulation. Other ongoing research interests include individual differences in the pharmacological and non-pharmacological factors that promote smoking, and environmental factors that moderate responses to nicotine or cigarette smoking.

Research Interests and Keywords
  • Nicotine dependence
  • Smoking Cessation
  • Tobacco use
Read More about Kenneth Perkins

View Investigators by Last Name

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z